CellCyte CEO Fraud Claims Can Move Forward

Law360, New York (April 29, 2010, 2:53 PM EDT) -- CellCyte Genetics Corp.'s former CEO has lost his bid to throw out U.S. Securities and Exchange Commission claims related to allegedly fraudulent statements that inflated the company's stock price, but the judge has ordered the agency to get more specific about its claims.

Although Judge Ricardo S. Martinez of the U.S. District Court for the Western District of Washington largely rejected Gary Reys' arguments challenging the SEC's claims against him, he agreed with Reys on Wednesday that the agency's allegations regarding the statements were too vague....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.